BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 33322484)

  • 1. In Vivo Tracking of Extracellular Vesicles by Nuclear Imaging: Advances in Radiolabeling Strategies.
    Almeida S; Santos L; Falcão A; Gomes C; Abrunhosa A
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
    Shahjin F; Chand S; Yelamanchili SV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging strategies for labeling and tracking of extracellular vesicles.
    Li YJ; Wu JY; Wang JM; Hu XB; Xiang DX
    J Control Release; 2020 Dec; 328():141-159. PubMed ID: 32882270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Update on
    Gangadaran P; Hong CM; Ahn BC
    Front Pharmacol; 2018; 9():169. PubMed ID: 29541030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation.
    Burnouf T; Agrahari V; Agrahari V
    Int J Nanomedicine; 2019; 14():8847-8859. PubMed ID: 32009783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.
    Sil S; Dagur RS; Liao K; Peeples ES; Hu G; Periyasamy P; Buch S
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):422-442. PubMed ID: 31456107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicle-based drug delivery systems for cancer treatment.
    Walker S; Busatto S; Pham A; Tian M; Suh A; Carson K; Quintero A; Lafrence M; Malik H; Santana MX; Wolfram J
    Theranostics; 2019; 9(26):8001-8017. PubMed ID: 31754377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles as an emerging drug delivery system for cancer treatment: Current strategies and recent advances.
    Wang Z; Mo H; He Z; Chen A; Cheng P
    Biomed Pharmacother; 2022 Sep; 153():113480. PubMed ID: 36076581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smart nano-sized extracellular vesicles for cancer therapy: Potential theranostic applications in gastrointestinal tumors.
    Lucchetti D; Colella F; Artemi G; Haque S; Sgambato A; Pellicano R; Fagoonee S
    Crit Rev Oncol Hematol; 2023 Nov; 191():104121. PubMed ID: 37690633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Inflammatory Vasculature by Extracellular Vesicles.
    Wang S; Dong X; Gao J; Wang Z
    AAPS J; 2018 Feb; 20(2):37. PubMed ID: 29484558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Invasive imaging of extracellular vesicles: Quo vaditis in vivo?
    Arifin DR; Witwer KW; Bulte JWM
    J Extracell Vesicles; 2022 Jul; 11(7):e12241. PubMed ID: 35844061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered extracellular vesicles and their mimetics for clinical translation.
    Kim H; Kim D; Nam H; Moon S; Kwon YJ; Lee JB
    Methods; 2020 May; 177():80-94. PubMed ID: 31626895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-Based Assays for Phenotyping of Extracellular Vesicles.
    Pugholm LH; Revenfeld AL; Søndergaard EK; Jørgensen MM
    Biomed Res Int; 2015; 2015():524817. PubMed ID: 26770974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in extracellular vesicles analysis.
    Vinaiphat A; Sze SK
    Adv Clin Chem; 2020; 97():73-116. PubMed ID: 32448435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separation, characterization, and standardization of extracellular vesicles for drug delivery applications.
    Buschmann D; Mussack V; Byrd JB
    Adv Drug Deliv Rev; 2021 Jul; 174():348-368. PubMed ID: 33964356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane vesicles nanotheranostic systems: sources, engineering methods, and challenges.
    Nie W; Wu G; Zhong H; Xie HY
    Biomed Mater; 2021 Feb; 16(2):022009. PubMed ID: 33307545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicles as drug delivery systems: Why and how?
    Elsharkasy OM; Nordin JZ; Hagey DW; de Jong OG; Schiffelers RM; Andaloussi SE; Vader P
    Adv Drug Deliv Rev; 2020; 159():332-343. PubMed ID: 32305351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface functionalization strategies of extracellular vesicles.
    Rayamajhi S; Aryal S
    J Mater Chem B; 2020 Jun; 8(21):4552-4569. PubMed ID: 32377649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
    Meng W; He C; Hao Y; Wang L; Li L; Zhu G
    Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.